|
gptkbp:instanceOf
|
gptkb:Insurance_Company
|
|
gptkbp:coInventor
|
Yes
|
|
gptkbp:fledgingPeriod
|
Acquisition
IPO
Secondary Sale
|
|
gptkbp:focusesOn
|
Biotechnology_Investments
|
|
gptkbp:foundedBy
|
gptkb:Dr._John_D._Maraganore
|
|
gptkbp:funding
|
$1 billion
$300 million
$500 million
|
|
gptkbp:geographicalFeature
|
gptkb:Asia
gptkb:North_America
Europe
|
|
gptkbp:headquarters
|
gptkb:Boston,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MPM Capital
|
|
gptkbp:investmentFocus
|
Medical Devices
Equity
Diagnostics
Early Stage
Strategic Partnerships
Debt
Therapeutics
Innovative Science
Company Creation
Convertible Notes
Market Potential
Regulatory Pathway
High Risk-High Reward
Long-Term Capital Gains
Growth_Capital
Strong_Management_Team
|
|
gptkbp:leads
|
Yes
|
|
gptkbp:notableEvent
|
gptkb:AstraZeneca
gptkb:Moderna
gptkb:Blueprint_Medicines
Kite Pharma
GRAIL
|
|
gptkbp:numberOfEmployees
|
51-200
|
|
gptkbp:partnerships
|
gptkb:Harvard_University
gptkb:Massachusetts_General_Hospital
gptkb:MIT
gptkb:Brigham_and_Women's_Hospital
|
|
gptkbp:portfolioCompany
|
gptkb:Zymeworks
gptkb:Syndax_Pharmaceuticals
gptkb:Sutro_Biopharma
TCR2 Therapeutics
Aileron Therapeutics
|
|
gptkbp:website
|
www.mpmcapital.com
|
|
gptkbp:yearEstablished
|
2001
|